Table 2 Geographical distribution of seroprevalence to CVBD agents among all the dogs included in the study

Northwestern

384

213 (55.47)^**

63 (16.4)^**

1 (0.26)

25 (6.51)

196 (51.04)^**

64 (16.67)^**

[50.3–60.2]

[12.8–20.1]

[0.0–0.8]

[4.2–9.4]

[46.1–56.0]

[12.5–20.3]

Northeastern

349

114 (32.66)

23 (6.59)^*

1 (0.29)

31 (8.88)^*

80 (22.9)^**

19 (5.44)^*

[27.8–37.5]

[4.3–9.2]

[0.0–0.8]

[6.0–12.0]

[18.6–27.5]

[3.4–8.0]

Northcentral

164

4 (2.44)^**

1 (0.61)^**

0 (0)

0 (0)^*

4 (2.43)^**

1 (0.61)^**

[0.6–4.9]

[0.0–1.8]

[0.0–0.0]

[0.0–0.0]

[0.6–4.9]

[0.0–1.8]

Western

140

54 (38.57)

14 (10)

0 (0)

3 (2.14)

52 (37.14)

15 (10.71)

[30.5–46.4]

[5.7–15.0]

[0.0–0.0]

[0.0–5.0]

[28.6–45.0]

[5.7–15.7]

Eastern

205

54 (26.34)^*

18 (8.78)

1 (0.49)

10 (4.88)

37 (18.05)^**

11 (5.37)

[20.5–32.2]

[4.9–12.7]

[0.0–1.5]

[2.0–7.8]

[13.0–23.4]

[2.4–8.8]

Southcentral

86

17 (19.77)^*

4 (4.65)

0 (0)

2 (2.32)

13 (15.12)^*

2 (2.32)^*

[11.6–29.1]

[1.2–9.3]

[0.0–0.0]

[0.0–5.8]

[8.1–23.3]

[0.0–5.8]

Southwestern

149

67 (44.97)^*

19 (12.75)

0 (0)

2 (1.34)^*

63 (42.3)^*

16 (10.74)

[36.9–53.0]

[7.4–18.8]

[0.0–0.0]

[0.0–3.4]

[34.2–50.3]

[6.0–16.1]

Southeastern

229

103 (44.98)^*

27 (11.79)

1 (0.44)

18 (7.86)

81 (35.37)

23 (10.04)

[38.4–51.5]

[7.4–16.2]

[0.0–1.3]

[4.8–11.8]

[29.3–41.5]

[6.6–14.0]

Mexican

states

1706

626 (36.7)

169 (9.91)

4 (0.23)

91 (5.33)

526 (30.83)

151 (8.85)

[34.3–39.0]

[8.6–11.4]

[0.1–0.5]

[4.3–6.4]

[28.7–33.1]

[7.5–10.2]